| Intermittent Fasting for NAFLD in Adults (NCT04899102) | Massachusetts General Hospital | 2022-02-01 |
| Impact of Time-restricted Feeding in NAFLD (NCT05220956) | Johannes Gutenberg University Mainz | 2021-10-01 |
| Anti-diabetic Drugs and Fatty Liver Management (NCT05041673) | Alexandria University | 2021-02-23 |
| Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease (NCT04761848) | Sadat City University | 2021-02-16 |
| Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH (NCT04702490) | Metacrine, Inc. | 2020-12-15 |
| Quantitative US for Evaluation of Hepatic Steatosis in NAFLD (NCT04462562) | Seoul National University Hospital | 2020-07-03 |
| Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages (NCT04241575) | Chinese University of Hong Kong | 2020-05-19 |
| Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy (NCT04452409) | Cairo University | 2020-01-10 |
| Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool (NCT04067440) | Universität des Saarlandes | 2019-10-01 |
| Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat (NCT04054297) | Maastricht University Medical Center | 2019-07-22 |
| Ketogenic Diet in Non-alcoholic Fatty Liver Disease (NCT03784716) | Marc Goodman | 2019-03-13 |
| Prevalence of NAFLD in T2DM Patients (NCT06445335) | Ziekenhuis Oost-Limburg | 2019-03-01 |
| Hepatic Glycogen and Fat Oxidation (NCT03593343) | Maastricht University Medical Center | 2019-01-08 |
| A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) (NCT03656744) | HighTide Biopharma Pty Ltd | 2018-11-26 |
| The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes (NCT04509245) | German Diabetes Center | 2018-10-01 |
| Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease (NCT03371355) | Akcea Therapeutics | 2017-12-21 |
| The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver (NCT03319199) | Rawi Hazzan | 2017-10-30 |
| Determinants of Liver Fat Composition (NCT03211299) | Maastricht University Medical Center | 2017-08-15 |
| The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease (NCT02983669) | Shiraz University of Medical Sciences | 2017-01-01 |
| Mechanism of Serum PRL in the Development of MAFLD (NCT05525884) | Shen Qu | 2017-01-01 |
| Efficacy and Safety of Fermented Ginseng Powder on Liver Function (NCT03260543) | Chonbuk National University Hospital | 2016-07-01 |
| Effects of Pitavastatin on Insulin Sensitivity and Liver Fat (NCT02290106) | Massachusetts General Hospital | 2015-03-02 |
| Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study (NCT02366052) | Johannes Gutenberg University Mainz | 2015-02-01 |
| Probiotics in the Treatment of NAFLD (NCT02764047) | Federal University of Health Science of Porto Alegre | 2015-01-01 |
| Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease (NCT02132780) | Virginia Commonwealth University | 2014-05-01 |